Home›Search›Rare Tumors

Rare Tumors

Page Press Publications · Italy · Est. 1963

ISSN2036-3605eISSN2036-3613

SJR Q3✓ WOS ESCI✓ Scopus / SJR✓ DOAJ✓ Open Access

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 75% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.37

H-Indexi

SNIPi

0.752

Total Worksi

703

Total Citationsi

6,915

2yr Mean Citednessi

1.06

Open Impact Factor alternative

Aims & Scope

Subject areas: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens. Topics: rare cancers, haematological malignancies, rare tumours

General Information

Country / RegionItaly

Primary LanguageEnglish

1st Year Published1963

FrequencyIrregular

StatusActive (last: 2026)

Total Publications703

Publisher OrgSAGE Publishing

OA Since2008

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

OA LicenseCC BY, CC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoPMC

Think.Check.Submit Compliance

thinkchecksubmit.org

10/11 · 91%

✅

Do you know the journal / publisher?

Page Press Publications

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2036-3605 / 2036-3613

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, PMC

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

198

2019

206

2020

177

2021

2022

126

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

HistologyQ3

OncologyQ3

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

OncologyHistology

Research Topics (OpenAlex)

Sarcoma Diagnosis and TreatmentCardiac tumors and thrombiVascular Tumors and AngiosarcomasBone Tumor Diagnosis and TreatmentsTumors and Oncological CasesSoft tissue tumor case studiesNeuroendocrine Tumor Research AdvancesCancer and Skin LesionsSalivary Gland Tumors Diagnosis and TreatmentUrologic and reproductive health conditions

Frequently asked questions about Rare Tumors

Is Rare Tumors a predatory journal?

PubScope has no integrity flags on record for Rare Tumors: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Rare Tumors?

Rare Tumors is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.06.

Is Rare Tumors indexed in Scopus and Web of Science?

Rare Tumors is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Rare Tumors?